Search results for: 'Procurement solutions'

The Asia-Pacific medical imaging and informatics market revenue is forecast to increase by 11.4% in 2023, mainly driven by the high procurement of medical imaging equipment and radiology IT solutions in the informatics sector. Large hospitals widely adopt digital radiography and ultrasound systems as the devices are operator-dependent and need a sk...

This study carries Frost & Sullivan’s observation of bone mineral density solutions in select Asian Countries (Australia, South Korea, and China); the regulatory trends for the same have been covered, highlighting the following: • Product registration and regulatory approval process details in select Asian countries (such as the Therapeutic Goods A...

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At AU...

28 Apr 2017  |  Asia Pacific  |  Market Research

End-user and Decision-maker Survey of Southeast Asian PACS Market, Forecast to 2021

Revenue Opportunities Continue to Exist Even as Market Advances toward Vendor-neutral Solutions

Infographics

×

The research service provides an in-depth analysis of the Picture Archiving and Communication System (PACS) market across six Southeast Asian countries with a focus on end-user and radiology decision-maker needs, challenges, and vendor preferences. The study provides opportunity analysis, vendor landscape, and evolving technology and business model...

In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry ...

13 Jul 2017  |  Asia Pacific  |  Market Research

China Medical Imaging Equipment Market, Forecast to 2021

Policies, Disruption, and the Future of Medical Imaging

Infographics

×

The study aims to analyze and forecast the healthcare imaging market in China (2017–2021). Research scope: Market trends, competitive structure, market metrics, market share, revenues, strategy, and government policies and initiatives. Regional scope: China (excluding Hong Kong) The study includes in-depth analysis of government-driven reforms, ...

The South Korean endoscopy devices market is growing under relatively lower reimbursement rates and budget constraints that are forcing hospitals to provide greater importance to pricing of equipment and changing utilization patterns. In many South Korean hospitals, consolidated purchasing of endoscopy and laparoscopy equipment slows down procureme...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...